We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Committee Votes in Favor of Glaucoma Drug’s Efficacy
FDA Committee Votes in Favor of Glaucoma Drug’s Efficacy
An FDA advisory committee voted 10-0 in favor of the efficacy of a drug candidate for treatment of glaucoma and ocular hypertension based on data from efficacy trials.